The altered syndecan expression and shedding levels support the notion that these cell surface receptors are involved in WB skeletal myopathy, adding to their importance as skeletal muscle regulators and molecular players in ECM-tissue homeostasis. The gene discussed is CD177; the disease is skeletal muscle disorder.